Holen Sie sich die Stockscreener-App
65.25
1.81%
1.16
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Bio Techne Corp Aktie (TECH) Neueste Nachrichten
Bio-Techne (TECH) Reports Earnings Tomorrow: What To Expect - Finviz
A Look At Bio Techne (TECH) Valuation After Cultrex Synthetic Hydrogel Launch - Yahoo Finance
Bio-Techne Corp (TECH) Stock Analysis: Unpacking the 9.22% Potential Upside Amidst Mixed Performance Metrics - DirectorsTalk Interviews
Bio-techne launches synthetic hydrogel for 3D stem cell research By Investing.com - Investing.com South Africa
Bio-Techne (TECH) Unveils New Cultrex Synthetic Hydrogel for 3D Research - GuruFocus
Bio-Techne expands 3D stem cell & organoid culture portfolio - marketscreener.com
Bio-techne launches synthetic hydrogel for 3D stem cell research - Investing.com
New lab-grown organoid gel aims to cut animal use and boost drug tests - Stock Titan
BIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS PRESIDENT, DIAGNOSTICS AND GENOMICS SEGMENT - Quantisnow
(TECH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock? - Yahoo Finance
Broadcrest Asset Management LLC Decreases Stake in Bio-Techne Corp $TECH - MarketBeat
Universal Beteiligungs und Servicegesellschaft mbH Buys 23,223 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp (NASDAQ:TECH) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Bio-techne launches ultra-sensitive neurological biomarker detection assays - Investing.com
Bio-Techne?Launches Simple?Plex?Ultra-Sensitive?Assays on Ella?Platform to Enable?Femtogram-Level?Detection of Neurological Biomarkers - Investing News Network
New Ella assays spot Alzheimer's-linked proteins in blood at femtogram levels - Stock Titan
Ownership Capital B.V. Cuts Stock Position in Bio-Techne Corp $TECH - MarketBeat
Campbell & CO Investment Adviser LLC Sells 30,867 Shares of Bio-Techne Corp $TECH - MarketBeat
How Investors May Respond To Bio-Techne (TECH) Doubling Down On Multi-Omic Integration Under New Leadership - Yahoo Finance
Massachusetts Financial Services Co. MA Trims Stake in Bio-Techne Corp $TECH - MarketBeat
Middle East Exosomes Market Research Report 2025-2033: Diagnostic and Therapeutic Adoption, R&D Investment, and Liquid Biopsy Demand Drive Growth - GlobeNewswire Inc.
(TECH) Risk Channels and Responsive Allocation - Stock Traders Daily
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results - Yahoo Finance
Bio-Techne Corp $TECH Shares Bought by Stephens Investment Management Group LLC - MarketBeat
Pembroke Management LTD Purchases 37,189 Shares of Bio-Techne Corp $TECH - MarketBeat
R&D Systems™ Luminex® Portfolio - Select Science
Here's what to expect from Bio-Techne's next earnings report - MSN
Bio-Techne Corp (TECH) Stock Analysis: Potential Upside and Analyst Confidence in the Biotech Arena - DirectorsTalk Interviews
Summit Creek Advisors LLC Sells 16,450 Shares of Bio-Techne Corp $TECH - MarketBeat
Conestoga Capital Advisors LLC Reduces Stake in Bio-Techne Corp $TECH - MarketBeat
HB Wealth Management LLC Sells 15,466 Shares of Bio-Techne Corp $TECH - MarketBeat
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors - MSN
(TECH) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Here's What to Expect From Bio-Techne's Next Earnings Report - Yahoo Finance
StreetInsider.comHere's What to Expect From Bio-Techne's Next Earnings Report - FinancialContent
A Look At Bio-Techne (TECH) Valuation After Analyst Downgrade And Softer Cash Flow Concerns - Yahoo Finance
Bio-Techne Corp. stock outperforms competitors on strong trading day - MSN
What technical signals suggest for Bio Techne Corporation stock - ulpravda.ru
What makes Bio Techne Corporation (TE1) stock appealing to growth investorsJuly 2025 News Drivers & Scalable Portfolio Growth Methods - Улправда
How Bio Techne Corporation (TE1) stock reacts to stronger dollar2025 Retail Activity & Safe Entry Momentum Tips - Улправда
Bio-Techne (NASDAQ:TECH) Stock Acquired Rep. April McClain Delaney - MarketBeat
Rep. April McClain Delaney Purchases Shares of Bio-Techne Corp (NASDAQ:TECH) - MarketBeat
Maryland Representative April McClain Delaney Purchased as Much as $135,000 in Bio-Techne Shares - Bitget
Bio-Techne (NASDAQ:TECH) Cut to Hold at Evercore ISI - MarketBeat
Evercore ISI Group downgrades Bio-Techne (TECH) - MSN
TECH: Evercore ISI Downgrades Bio-Techne's Rating and Lowers Pri - GuruFocus
3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Finviz
Should Bio-Techne’s (TECH) Revenue Miss Raise Doubts About Its Scientific Platform’s Commercial Potential? - simplywall.st
Bio-Techne Corp (NASDAQ:TECH) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Fort Washington Investment Advisors Inc. OH Buys 35,165 Shares of Bio-Techne Corp $TECH - MarketBeat
Research Tools & Consumables Stocks Q3 Results: Benchmarking Bio-Techne (NASDAQ:TECH) - Yahoo Finance
Bio-Techne Corp (TECH): Stock Analysis Reveals A 17.64% Potential Upside For Investors - DirectorsTalk Interviews
Bio-Techne Corp (TECH) Stock Price History & Data - Traders Union
Voya Investment Management LLC Has $7.04 Million Holdings in Bio-Techne Corp $TECH - MarketBeat
Assenagon Asset Management S.A. Invests $2.75 Million in Bio-Techne Corp $TECH - MarketBeat
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference - Investing News Network
Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Bio-Techne (TECH): Revisiting Valuation as Recent Gains Contrast a Weak One-Year Shareholder Return - Yahoo Finance
Bio-Techne Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
0.22%
4.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):